Total planned funding: $529,124,954
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $529,124,954 |
Organizational Types
Private Contractor | $159,194,079 |
NGO | $157,852,949 |
Unknown | $95,219,914 |
Own Agency | $63,344,717 |
Implementing Agency | $35,733,370 |
FBO | $6,039,141 |
University | $5,399,468 |
Multi-lateral Agency | $3,726,316 |
Other USG Agency | $1,615,000 |
Host Country Government Agency | $1,000,000 |
Program Areas
Treatment | $176,907,643 |
Prevention | $114,927,859 |
Care | $107,387,169 |
Testing | $49,098,501 |
Governance and Systems | $42,054,264 |
Management and Operations | $38,749,518 |
Budget Codes
HTXD: Treatment: ARV Drugs | $86,296,846 |
HTXS: Treatment: Adult Treatment | $82,481,952 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $63,653,467 |
HKID: Care: Orphans and Vulnerable Children | $57,390,932 |
HVCT: Testing: HIV Testing and Counseling | $49,098,501 |
HVMS: Management and Operations | $38,749,518 |
HBHC: Care: Adult Care and Support | $29,824,488 |
OHSS: Health Systems Strengthening | $22,203,056 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,903,508 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,337,402 |
HVTB: Care: TB/HIV | $14,181,541 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,133,482 |
HVSI: Strategic Information | $12,242,531 |
PDTX: Treatment: Pediatric Treatment | $8,128,845 |
HLAB: Laboratory Infrastructure | $7,608,677 |
PDCS: Care: Pediatric Care and Support | $5,990,208 |
HMBL: Biomedical Prevention: Blood Safety | $800,000 |
HMIN: Biomedical Prevention: Injection Safety | $100,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$97,761,104
Countries/Regions
Not Available:
$95,799,914
Countries/Regions
USG Aggregated Agencies:
$51,508,367
Countries/Regions
University of Washington:
$44,572,651
Countries/Regions